Publications
739
Citations
18,911
Est. group size
~79
Recurring co-author estimate
Active years
52
Publishing since 1975
Typically publishes in teams of ~14 · 6% small-team papers (≤3 authors) · across 76 venues
- Real-world treatment patterns, recurrence, and overall survival of patients with muscle-invasive bladder cancer undergoing radical cystectomy in U.S. oncology practice
Urologic Oncology Seminars and Original Investigations · 2026
- IP31-02 NON-INVASIVE URINE TEST PREDICTS THE NEED FOR BIOPSY IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER: PROSPECTIVE MULTISITE VALIDATION AND COMPARISON WITH MRI
The Journal of Urology · 2026
- IP20-28 FREEDOM FROM BLADDER CANCER: TIME-TO-EVENT REPORTING IN CIS+ BCG-UNRESPONSIVE TRIALS
The Journal of Urology · 2026
- Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Prospective Multisite Validation and Comparison with MRI
The Journal of Urology · 2026
- Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer
Clinical Genitourinary Cancer · 2026
- Investigating the Use of Biomaterial Scaffolds to Detect Circulating Tumor Cells in Prostate Cancer
Michigan Journal of Medicine · 2026
- Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Journal of Clinical Oncology · 2025
- Knowledge and Worry Following Review of Standard vs Patient-Centered Pathology Reports
JAMA · 2025
- Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
JCO Clinical Cancer Informatics · 2025
- Trends in Surgical Overtreatment of Prostate Cancer
JAMA Oncology · 2025
- Development and Validation of a Multimodal Artificial Intelligence–derived Digital Pathology–based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG Trials
European Urology · 2025
- Biparametric Prostate MRI Is Safe and Effective if Image Quality Is Excellent
JAMA · 2025
- Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Prostate Cancer and Prostatic Diseases · 2025
- Abnormal Flagging of Prostate Specific Antigen Screening Tests: A Regression Discontinuity Design
Journal of General Internal Medicine · 2025
- Recurrence and its association with overall survival (OS) in muscle-invasive bladder cancer (MIBC) patients undergoing radical cystectomy (RC): A real-world analysis.
Journal of Clinical Oncology · 2025
- The Journal of Urology×117
- Journal of Clinical Oncology×55
- European Urology×37
- Urologic Oncology Seminars and Original Investigations×23
- International Journal of Radiation Oncology*Biology*Physics×22
- Ganesh S. Palapattu
Medicine · University of Michigan
- Simpa S. Salami
Medicine · University of Michigan
- Suguru Kadomoto
Medicine · University of Michigan
- Stephanie Daignault
Medicine · University of Michigan
- Lakshmi P. Kunju
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile